Post-VX exposure treatment of rats with engineered phosphotriesterases

The biologically stable and highly toxic organophosphorus nerve agent (OP) VX poses a major health threat. Standard medical therapy, consisting of reactivators and competitive muscarinic receptor antagonists, is insufficient. Recently, two engineered mutants of the Brevundimonas diminuta phosphotrie...

Descripción completa

Detalles Bibliográficos
Autores principales: Stigler, Lisa, Köhler, Anja, Koller, Marianne, Job, Laura, Escher, Benjamin, Potschka, Heidrun, Thiermann, Horst, Skerra, Arne, Worek, Franz, Wille, Timo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Molecular Toxicology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837561/
https://www.ncbi.nlm.nih.gov/pubmed/34962578
http://dx.doi.org/10.1007/s00204-021-03199-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837561/
https://www.ncbi.nlm.nih.gov/pubmed/34962578
http://dx.doi.org/10.1007/s00204-021-03199-6

Ejemplares similares